# Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)

> **NCT00261300** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 100 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease (GERD)
- Peptic Ulcers

## Interventions

- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT00261300
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** 2007-09
- **Final completion:** 2008-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261300, "Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00261300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*